These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
News & Analysis: Invitae
These fast-growing companies are leveraging advances in genetic insight in ways that could pay off big for investors.
The company's making progress in its goal to make genetic screening for healthcare available to everyone.
Big gains don't have to come from low-price stocks.
Quarterly earnings from around the industry suggested the epic growth opportunity isn't slowing down anytime soon.
Earnings and a proposed equity raise have these stocks making after-hours moves.
The genetic-testing leader is trading at multiyear highs on the heels of impressive growth in 2018, but it still isn't profitable.
NVTA earnings call for the period ending December 31, 2018.
The group rebounded after a terrible end to 2018, but each has big plans for the year ahead.
Do these under-the-radar stocks deserve a spot in your growth stock portfolio?